Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-80
SponsorHenan University of Traditional Chinese Medicine

About this trial

This study aims to evaluate the clinical efficacy of traditional Chinese medicine formula granules (Fei Re Qing Granules) in the treatment of elderly community-acquired pneumonia, establish a treatment protocol, and obtain high-level clinical evidence.

Eligibility criteria

Qualifiers

Inpatients diagnosed with community-acquired pneumonia (CAP) according to the diagnostic criteria.

Diagnosed with Phlegm-Heat Obstructing the Lungs syndrome based on Traditional Chinese Medicine (TCM).

Aged ≥65 and ≤80 years, regardless of gender.

Onset of illness within 72 hours.

Disqualifiers

Patients with altered mental status, consciousness disorders, dementia, or psychiatric disorders.

Patients requiring invasive mechanical ventilation or endotracheal intubation.

Patients with conditions such as pleural effusion, bronchiectasis, active pulmonary tuberculosis, pulmonary abscess, lung cancer, asthma, or chronic obstructive pulmonary disease (COPD).

Patients with neuromuscular diseases or those bedridden for long periods, posing a risk of aspiration.

Trial design

Treatments tested in this trial

  • Fei Re Qing Granules
  • Routine standard treatments
  • Placebo granules

Treatment groups

120 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Henan University of Traditional Chinese Medicine

Lead sponsor

Third Affiliated Hospital of Henan University of Traditional Chinese Medicine

Collaborator

The First Affiliated Hospital of Henan university of CM

Collaborator